Related Experiment Videos
Plasma transcobalamins in haematological disorders.
Folia Haematologica (Leipzig, Germany : 1928)
|January 1, 1986
Summary
Plasma vitamin B12 (UBBC-B12) and transcobalamin levels vary significantly across different hematological disorders. These protein changes offer insights into disease status and progression in various blood cancers and anemias.
Area of Science:
- Hematology
- Clinical Biochemistry
- Oncology
Background:
- Vitamin B12 is crucial for normal cell growth and DNA synthesis.
- Transcobalamins are proteins that transport vitamin B12 in the blood.
- Altered levels of vitamin B12 and its binding proteins can indicate hematological abnormalities.
Purpose of the Study:
- To investigate plasma unbound B12 (UBBC-B12) and transcobalamin levels in patients with diverse hematological disorders.
- To identify specific patterns of these markers associated with different hematological conditions.
Main Methods:
- Measurement of plasma UBBC-B12 and transcobalamins.
- Analysis of data from 112 patients diagnosed with various hematological disorders.
Main Results:
- Significantly elevated levels were observed in untreated chronic myeloid leukemia, acute promyelocytic leukemia, nutritional megaloblastic anemia, and refractory anemias.
- Normal levels were found in chronic lymphatic leukemias, hypereosinophilic states, and multiple myeloma.
- Subnormal levels were noted in hypoplastic anemia and acute lymphoblastic leukemia; variable patterns were seen in CML blast crisis and AML subtypes.
Conclusions:
- Plasma transcobalamin profiles exhibit distinct changes correlating with specific hematological disorders.
- These alterations may serve as potential biomarkers for disease status and progression.
- Further research is warranted to elucidate the precise clinical significance of these findings.